Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Hay

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Blood|June 1, 1987
Predictive markers of chronic liver disease in hemophiliaC R Hay, F E Preston, D R Triger, et al.
Annals of Tropical Medicine and Parasitology|June 1, 1992
Coagulation abnormalities and ivermectinJ A Whitworth, C R Hay, A M McNicholas, et al.
Lancet (London, England)|September 9, 1989
Cytomegalovirus, serum beta 2 microglobulin, and progression to AIDS in HIV-seropositive haemophiliacsF P Rugman, P T Mannion, C R Hay, et al.
Thrombosis and Haemostasis|April 2, 1992
The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Butantan Institute Antivenom Study GroupA S Kamiguti, F P Rugman, R D Theakston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2014
Is it congenital or acquired von Willebrands disease?M A Saif, J Thachil, R Brown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
VIM-D salvage chemotherapy in Hodgkin's diseaseJ K Phillips, R L Spearing, J M Davies, et al.
British Journal of Haematology|July 23, 1998
The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparisonC R Hay, C A Ludlam, G D Lowe, et al.
Thrombosis Research|April 15, 1987
Lack of effect of a 24-hour infusion of iloprost in intermittent claudicationC R Hay, P C Waller, C Carter, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
Seminars in Hematology|April 1, 1994
Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effectsC R Hay, J N Lozier, C A Lee, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Blood|June 1, 1987
Predictive markers of chronic liver disease in hemophiliaC R Hay, F E Preston, D R Triger, et al.
Annals of Tropical Medicine and Parasitology|June 1, 1992
Coagulation abnormalities and ivermectinJ A Whitworth, C R Hay, A M McNicholas, et al.
Lancet (London, England)|September 9, 1989
Cytomegalovirus, serum beta 2 microglobulin, and progression to AIDS in HIV-seropositive haemophiliacsF P Rugman, P T Mannion, C R Hay, et al.
Thrombosis and Haemostasis|April 2, 1992
The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Butantan Institute Antivenom Study GroupA S Kamiguti, F P Rugman, R D Theakston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2014
Is it congenital or acquired von Willebrands disease?M A Saif, J Thachil, R Brown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
VIM-D salvage chemotherapy in Hodgkin's diseaseJ K Phillips, R L Spearing, J M Davies, et al.
British Journal of Haematology|July 23, 1998
The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparisonC R Hay, C A Ludlam, G D Lowe, et al.
Thrombosis Research|April 15, 1987
Lack of effect of a 24-hour infusion of iloprost in intermittent claudicationC R Hay, P C Waller, C Carter, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
Seminars in Hematology|April 1, 1994
Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effectsC R Hay, J N Lozier, C A Lee, et al.
Pageof 7